Pfizer stock today: PFE ends first 2026 session higher as pricing scrutiny returns and Feb. 3 results loom
Pfizer Inc shares last closed up 1.1% at $25.18 on Friday, after a weak finish to 2025. U.S. markets were closed on Saturday.
AbbVie stock slides 4% as pharma lags Wall Street rally — what investors watch next for ABBV
AbbVie Inc shares closed down 4% on Monday at $220.18, lagging a Wall Street rally that pushed the Dow to a record high.
Healthcare Stocks Today: XLV edges up as drugmakers raise U.S. list prices on 350 medicines
Drugmakers are lifting U.S. list prices on hundreds of medicines as 2026 begins, putting drug-pricing politics back in focus for healthcare investors. The sector finished higher in Friday’s session, the last U.S. trading day before the weekend.
Johnson & Johnson stock ticks up after $1.30 dividend; earnings next on the radar
Johnson & Johnson shares ended Friday up 0.19% at $207.35 after the healthcare company said its board declared a $1.30-per-share cash dividend for the first quarter of 2026. Yahoo Finance
Pfizer stock rises today as 2026 drug price hikes grab headlines again — what PFE investors are watching
Pfizer Inc shares rose 0.8% to $25.09 on Friday, as investors digested renewed attention on U.S. drug pricing and early-year list-price changes.
Pfizer stock slips before the bell as 2026 drug price hikes put PFE back in focus
Pfizer Inc shares fell 0.4% to $24.90 in premarket trading on Friday after a Reuters report said the drugmaker plans to raise U.S. list prices on around 80 medicines in 2026. Reuters
Pfizer stock today: PFE slips as report flags 2026 U.S. drug price hikes
Pfizer Inc shares last traded at $24.90, down 0.4% from the previous close, with U.S. markets closed on Thursday for the New Year’s Day holiday. Reuters reported Pfizer is leading a new round of U.S. list-price increases for 2026, planning hikes on around 80 drugs and vaccines — including a 15% rise for its COVID-19 shot Comirnaty — as drugmakers overall line up price increases on at least 350 branded medicines, with a median hike of about 4%. “They really just nibble around the margins,” said Dr. Benjamin Rome, a health policy researcher at Brigham and Women’s Hospital, while Pfizer said its average increase for innovative medicines and vaccines would be below inflation. Reuters
Pfizer stock in focus on New Year’s Day after report of 2026 U.S. drug price hikes
Pfizer Inc shares were last indicated slightly lower after hours on Wednesday after a report said the drugmaker plans to raise U.S. list prices on about 80 medicines in 2026. U.S. stock markets were closed on Thursday for the New Year’s Day holiday.
Pfizer stock today: PFE in focus as 2026 U.S. drug price hikes kick off — what to watch next
Pfizer Inc is in focus after annual U.S. drug pricing changes for 2026 included increases on some of its medicines, a politically sensitive topic heading into the new year. Pfizer shares last closed down 0.36% at $24.90 on Wednesday after trading between $24.88 and $25.02, with about 29.4 million shares changing hands.
Pfizer stock dips after-hours as 2026 drug price hike list puts PFE in the spotlight
Pfizer Inc. shares fell about 0.4% to $24.90 in after-hours trading on Wednesday, after a report said the drugmaker is leading a wave of U.S. list-price increases set for 2026. The data, compiled by healthcare research firm 3 Axis Advisors, showed drugmakers plan hikes on at least 350 branded medicines, with Pfizer accounting for around 80 increases, including a 15% rise for its COVID vaccine Comirnaty. “They really just nibble around the margins,” said Dr. Benjamin Rome, a health policy researcher at Brigham and Women’s Hospital in Boston. Reuters
Pfizer stock today: PFE slips after report on 2026 U.S. drug price hikes
Pfizer shares were down 0.1% at $24.96 in afternoon trade on Wednesday after a Reuters report said the drugmaker plans U.S. list-price hikes on about 80 medicines in 2026. Reuters
Pfizer stock flat before the bell as report flags 2026 U.S. drug price hikes, including 15% Comirnaty rise
Pfizer Inc shares were little changed in premarket trading on Wednesday after a report showed the drugmaker is leading a new round of U.S. list-price increases for 2026. The stock was down about 0.02% at $24.99, after closing Tuesday at roughly $25.00.
Pfizer stock flat after hours as TD Cowen sticks with Hold; Feb. 3 results ahead
Pfizer Inc. shares were little changed in late after-hours trading on Tuesday, down about 0.02% at $24.99, after moving between $24.92 and $25.10 in the regular session. After-hours trading is the session after the 4 p.m. ET close, when volumes can be thinner and moves can be sharper.
Pfizer stock today: PFE edges up after TD Cowen sticks with Hold as investors size up 2026 outlook
Pfizer Inc shares were up about 0.1% at $25.03 in afternoon trading on Tuesday, after moving between $24.92 and $25.10. TD Cowen reiterated its Hold rating and kept a $30 price target, pointing to negative trends in its model through 2030 despite the stock’s dividend yield near 7%. Investing.com
Pfizer stock today: PFE holds near $25 as year-end trading turns to Fed minutes and next earnings
Pfizer Inc shares were last down 0.3% at $25.00 in after-hours trading, after ending Monday at $25.09. The stock traded between $24.98 and $25.19 in the regular session.
Pfizer stock slips after hours: what traders are watching ahead of Feb. 3 results
Pfizer Inc shares were down 0.3% at $25 in after-hours trading on Monday, after moving in a tight band during the regular session. The Health Care Select Sector SPDR Fund slipped and large-cap drugmakers traded mixed in late dealings.
Pfizer stock today: PFE edges down as Wall Street looks to Feb. 3 results update
Pfizer shares dipped slightly on Monday, trading down about 0.1% at $25.06 as of 2:08 p.m. ET. The stock has moved between $24.99 and $25.19 in the regular session.
Pfizer filings spotlight big portfolio shifts as Live Oak slashes stake 92%
Live Oak Private Wealth LLC cut its stake in Pfizer by 92.5% in the third quarter, selling 216,868 shares and ending the period with 17,627 shares, a regulatory filing showed. MarketBeat+2SEC+2
Pfizer stock holds near $25 as Wall Street waits for the next big catalyst
Pfizer Inc shares edged higher in the last U.S. session, closing Friday up 0.24% at $25.09. The stock traded between $24.92 and $25.11 on the day. Investing.com
Pfizer Stock (NYSE: PFE) Holds Near $25 as Markets Close for the Weekend: Latest News, Analyst Targets, and What to Watch Monday
Pfizer Inc. heads into the final week of 2025 with its shares hovering in the mid-$20s — a level Wall Street has increasingly framed as a “show-me” zone for investors who want evidence that Pfizer can navigate the post-COVID comedown and looming patent expirations while rebuilding growth through oncology and obesity-focused deals.
TechStock² Updates
